Breast cancer adjuvant chemotherapy decisions in older women: the role of patient preference and interactions with physicians. - Wikidata - awgldk - TriplyDB

Breast cancer adjuvant chemotherapy decisions in older women: the role of patient preference and interactions with physicians.

Breast cancer adjuvant chemotherapy decisions in older women: the role of patient preference and interactions with physicians.

http://www.wikidata.org/entity/Q33990818

about

Long-term trajectories of self-reported cognitive function in a cohort of older survivors of breast cancer: CALGB 369901 (Alliance).A prospective cohort study of early discontinuation of adjuvant chemotherapy in women with breast cancer: the breast cancer quality of care study (BQUAL).Frailty and adherence to adjuvant hormonal therapy in older women with breast cancer: CALGB protocol 369901.Designing therapeutic clinical trials for older and frail adults with cancer: U13 conference recommendations Breast conserving surgery versus mastectomy: the influence of comorbidities on choice of surgical operation in the Department of Defense health care system Quality of life among a population-based cohort of older patients with breast cancer.Preferences related to attention-deficit/hyperactivity disorder and its treatment.Patient preferences and treatment adherence among women diagnosed with metastatic breast cancer Effects of comorbidities and functional living activities on survival in geriatric breast cancer patients.Cost-effectiveness analysis of prognostic gene expression signature-based stratification of early breast cancer patients Associations among survivorship care plans, experiences of survivorship care, and functioning in older breast cancer survivors: CALGB/Alliance 369901.What Black Women Know and Want to Know About Counseling and Testing for BRCA1/2 Occupational type affects the receipt of breast cancer adjuvant chemotherapy in China.Patient and physician decision styles and breast cancer chemotherapy use in older women: Cancer and Leukemia Group B protocol 369901.Noninitiation of adjuvant chemotherapy in women with localized breast cancer: the breast cancer quality of care study Non-initiation of adjuvant hormonal therapy in women with hormone receptor-positive breast cancer: The Breast Cancer Quality of Care Study (BQUAL).Interpersonal influences and attitudes about adjuvant therapy treatment decisions among non-metastatic breast cancer patients: an examination of differences by age and race/ethnicity in the BQUAL study.Narrowing racial gaps in breast cancer chemotherapy initiation: the role of the patient-provider relationship.Psychosocial factors related to non-persistence with adjuvant endocrine therapy among women with breast cancer: the Breast Cancer Quality of Care Study (BQUAL)Consultations between patients with breast cancer and surgeons: a pathway from patient-centered communication to reduced hopelessness.Factors associated with receipt of adjuvant chemotherapy among married women with breast cancer.The impact of comorbidity on cancer survival: a review Impact of genomic testing and patient-reported outcomes on receipt of adjuvant chemotherapy A planned, prospective comparison of short-term quality of life outcomes among older patients with breast cancer treated with standard chemotherapy in a randomized clinical trial vs. an observational study: CALGB #49907 and #369901.Are we missing the Institute of Medicine's mark? A systematic review of patient-reported outcome measures assessing quality of patient-centred cancer care.Patterns of 21-gene assay testing and chemotherapy use in black and white breast cancer patients.Adjuvant Chemotherapy Use and Health Care Costs After Introduction of Genomic Testing in Breast Cancer.How Informed Is the Decision About Breast Reconstruction After Mastectomy?: A Prospective, Cross-sectional Study.Present status of adjuvant chemotherapy for elderly breast cancer patients.Patient preferences versus physicians' judgement: does it make a difference in healthcare decision making?Influence of comorbidity on chemotherapy use for early breast cancer: systematic review and meta-analysis.Adjuvant chemotherapy in elderly patients with breast cancer: key challenges.Frailty and long-term mortality of older breast cancer patients: CALGB 369901 (Alliance).Lung cancer chemotherapy decisions in older patients: the role of patient preference and interactions with physicians.Studies of Physician-Patient Communication with Older Patients: How Often is Hearing Loss Considered? A Systematic Literature Review.Survival benefit needed to undergo chemotherapy: Patient and physician preferences."Rather one more chemo than one less…": Oncologists and Oncology Nurses' Reasons for Aggressive Treatment of Young Adults with Advanced Cancer.Cognitive function and discontinuation of adjuvant hormonal therapy in older breast cancer survivors: CALGB 369901 (Alliance).Oncologists' End of Life Treatment Decisions.Chemotherapy in Old Women with Breast Cancer: Is Age Still a Predictor for Under Treatment?

P2860

Q30489606-41954727-941D-4983-87D1-4841F90758E4 Q33857602-39386DD1-52D5-403D-A719-D2C88D725F28 Q33927985-4DC66938-6D5E-439E-BC89-4FACF8C4E5A5 Q34031134-C2CA95FD-C985-4D9C-A76B-E214E3CB4C32 Q34107526-6BBB9716-6AA9-4224-940C-EC2906507458 Q34287873-D938E420-AC19-4E12-AC5B-005761C044EA Q34554897-929CAFB2-4D9D-458E-A1AD-C7B887164523 Q34720400-AAA5A63E-F899-4B1C-8CDC-33AADE5805D4 Q34721587-F52101AE-6467-402D-8AAD-12984A23C061 Q35008290-1CC09860-F01F-4AD3-855E-7E9991ECF184 Q35282908-5B2FAC9D-54DC-4A78-A027-D410C6989F09 Q35370858-AEA7DB95-23E1-468B-B105-F6946EEAD3BD Q36086033-6D32B2C7-208E-4594-9204-3779650F77C9 Q36145423-45BB9D87-83A0-40DD-8511-6663C28B8196 Q36339703-0196A8BE-10B3-43A3-8809-3F1D94CF2070 Q36579191-F5D0122E-E450-4588-9519-797F9BAF1A50 Q36584533-02B2A624-8D2D-4B55-8A97-4F7D0959211D Q36869851-383E7643-AC0D-472F-AB51-12005C681BCF Q36901989-3A801207-81F1-4FB7-BE87-88D8FC7ACAC2 Q37065974-207E25CE-07BA-4D78-BAF2-306A4790C2C7 Q37276942-BE7A79EC-2CB3-4144-893D-6717F7DE753A Q37288186-D92EB1DD-8F0E-4AB4-B042-CDC4899BF9C6 Q37342385-F1481535-8E4B-432D-8CB5-06289BC38726 Q37542432-0B97626C-907F-4BC6-A2AB-63A20C3669BF Q37566641-41FDC8CB-9733-473E-B321-A47183ACDBFD Q37606937-33B347C4-57B4-4E1A-90C3-4B7260F90684 Q37659082-BFB3E357-2648-4A4F-A989-CE7507B53686 Q37677168-A4831F74-B0E7-4FEC-8D29-C01AC676FBFA Q37677693-9105DF39-D04B-4E7B-ABEC-78C5AFE18121 Q38093110-AFD15788-9817-4725-871E-6BF486A926BC Q38772800-F7B92030-76B2-441C-84BC-270DC9A1B9A4 Q38787215-34315C44-592B-4F6D-A3EC-762A5E7FBC5B Q38863741-8BB56FA1-E1E7-414A-A57C-D4D6576F3707 Q39251171-45B11D1C-1576-430E-B8CB-CB7188F808B2 Q39258019-1547D131-D1D9-4582-AB43-15FB2515204A Q40282933-0F403D53-6897-499F-8073-F9E453C2CA83 Q47218736-C349999F-F4A7-4B44-B98A-CED3236DC4E7 Q47573348-5AA52113-CEE7-4846-8B14-D621D46692CF Q47630207-048E48D0-77AA-4C8E-BA5C-930730E0CF7C Q48034006-15F8C0B0-5DC7-4C37-B940-C3ACDB20B7C1

P2860

Breast cancer adjuvant chemotherapy decisions in older women: the role of patient preference and interactions with physicians.

http://www.wikidata.org/entity/Q33990818

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Breast cancer adjuvant chemoth ...... interactions with physicians.

@ast

Breast cancer adjuvant chemoth ...... interactions with physicians.

@en

type

label

Breast cancer adjuvant chemoth ...... interactions with physicians.

@ast

Breast cancer adjuvant chemoth ...... interactions with physicians.

@en

prefLabel

Breast cancer adjuvant chemoth ...... interactions with physicians.

@ast

Breast cancer adjuvant chemoth ...... interactions with physicians.

@en

P1433

Q33990818-0CED5B9C-36C2-4B00-8BCD-573C4CA62C66

P1476

Q33990818-530FE47D-757D-4CF4-89FA-C06091551D53

P2093

Q33990818-2ACBB6C4-69C7-46E7-8144-4AC45B7CA078

Q33990818-4E1B5633-5587-421E-9BD9-E1FF65A2B245

Q33990818-58DE6160-B3E4-412D-A94E-9055E27BB898

Q33990818-5E93FC7B-0B34-44F3-8F7F-5DF26780BEEE

Q33990818-634A449C-DCCE-49C4-AC2F-58CD9E0F3812

Q33990818-674C5B4A-EDCA-48A7-98BB-1FCE7E777615

Q33990818-6BD1B01E-D875-4CAE-8EFA-29BD6B00BA80

Q33990818-73342F5A-1064-45BC-ACA1-68CB147B213A

Q33990818-799EB508-8DD0-4015-8A87-6AE74D260ABC

Q33990818-7B35E3D4-0E98-495E-95DA-C80E36990E2A

P2860

Q33990818-03841F7F-A728-4EEB-8D9B-D6128943471D

Q33990818-05DC7424-30AE-442C-98EB-020A101D5A58

Q33990818-063AF87C-C7EA-4E83-9252-C7F48129FDD7

Q33990818-08E2748E-2320-484E-A491-2E962B4B1D9F

Q33990818-12F23CCC-AB0D-4DE0-B8FA-84A68E8378B1

Q33990818-134D5CC9-85BB-463F-9F7A-2E0F76DB5379

Q33990818-17635EBF-3C5D-4D60-9C8D-A646F98AA476

Q33990818-17C11E94-2C51-4FF4-9099-78E899C86D3A

Q33990818-1986AAE5-4C43-46F5-ADA4-31B5A4A9C7CA

Q33990818-1D1C6513-391B-4259-B0B8-51117C9A7A61

P304

Q33990818-858A8CC4-500C-4B24-A6D7-9459DFB9F4EE

P31

Q33990818-9E155468-7784-4A83-99B6-530C99992855

P356

Q33990818-0EA02790-4DBE-4A02-9C80-4A3A88AC11BB

P407

Q33990818-BBB6A8EB-B899-414B-89AB-C7BFC9EE9FB0

P433

Q33990818-475A7AA5-7FDE-49E5-97CA-D96E9873A18D

P478

Q33990818-DCA7E4D9-FF3C-4B4C-87F2-8F2015D9FFFB

P50

Q33990818-4EADF420-7E97-4BCA-B350-AA964098E001

P577

Q33990818-69C1F63F-D78C-41DE-BC39-537C58C9DA34

P5875

Q33990818-24AC3F87-16D5-4D1D-B0B0-1D5C3DA01FA5

P698

Q33990818-BF6A1D00-26C1-46DE-B6C5-C66D023BD15C

P921

Q33990818-2732FF8A-886B-42D3-9FCF-71D2A57DA6D1

P932

Q33990818-C4D17533-D05B-4658-86FB-B6F7050AF3AA

P356

JCO.2009.24.3295

P1433

Journal of Clinical Oncology

P1476

Breast cancer adjuvant chemoth ...... interactions with physicians.

@en

P2093

Alice B Kornblith

http://www.w3.org/2001/XMLSchema#string

Anne-Michelle Noone

http://www.w3.org/2001/XMLSchema#string

Arti Hurria

http://www.w3.org/2001/XMLSchema#string

Cancer Leukemia Group B

http://www.w3.org/2001/XMLSchema#string

Clifford Hudis

http://www.w3.org/2001/XMLSchema#string

Eric Winer

http://www.w3.org/2001/XMLSchema#string

Gheorghe Luta

http://www.w3.org/2001/XMLSchema#string

Gretchen Kimmick

http://www.w3.org/2001/XMLSchema#string

Harvey Jay Cohen

http://www.w3.org/2001/XMLSchema#string

Hyman Muss

http://www.w3.org/2001/XMLSchema#string

P2860

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Patterns of use of chemotherapy for breast cancer in older women: findings from Medicare claims data.

Effect of undertreatment on the disparity in age-related breast cancer-specific survival among older women.

Physicians' communication and perceptions of patients: is it how they look, how they talk, or is it just the doctor?

Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older.

Patients' preferences for adjuvant chemotherapy in early breast cancer: a review of what makes it worthwhile.

Adjuvant chemotherapy in older women with early-stage breast cancer.

Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public

P304

3146-3153

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2009.24.3295

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Claudine Isaacs

P577

2010-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44643453

http://www.w3.org/2001/XMLSchema#string

P698

20516438

http://www.w3.org/2001/XMLSchema#string

P921

P932

2903313

http://www.w3.org/2001/XMLSchema#string